Candida dubliniensis isolated from the sputum of a patient with end-stage liver cirrhosis.
Candida dubliniensis is rare and very similar to C. albicans. To date, detailed clinical reports on C. dubuliniensis recovered from an immunocompromised patient have not been described in Japan. A 71-year-old man with end-stage liver cirrhosis had been treated for suppurative omarthritis due to methicillin-resistant Staphylococcus aureus (MRSA). Anti-MRSA agents and broad-spectrum antimicrobials but no antifungal agents had been administrated. C. dubliniensis, isolated from the sputum, was eliminated by selective digestive decontamination and supportive therapy. This case emphasizes the need to recognize this emerging Candida sp., C. dubliniensis in cases of opportunistic infection.
Tsuruta
Ryosuke
R
Advanced Medical Emergency and Critical Care Center, Ube, Japan. ryosan-ygc@umin.ac.jp <ygc@umin.ac.jp>
Oda
Yasutaka
Y
Mizuno
Hidekazu
H
Hamada
Hirotaka
H
Nakahara
Takashi
T
Kasaoka
Shunji
S
Maekawa
Tsuyoshi
T
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001168:Arthritis / Q000150:complications / Q000382:microbiology; D044466:Asian People; D002175:Candida / Q000302:isolation & purification*; D002177:Candidiasis / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000382:microbiology*; D017093:Liver Failure / Q000209:etiology* / Q000382:microbiology*; D008297:Male; D016106:Methicillin Resistance; D012785:Shoulder Joint; D013183:Sputum / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus / Q000502:physiology; D013492:Suppuration
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents